Emergent Biosolutions
EBS
EBS
181 hedge funds and large institutions have $1.2B invested in Emergent Biosolutions in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 78 increasing their positions, 56 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.5% less ownership
Funds ownership: 87.44% → 86.95% (-0.5%)
64% less call options, than puts
Call options by funds: $1.94M | Put options by funds: $5.37M
Holders
181
Holding in Top 10
–
Calls
$1.94M
Puts
$5.37M
Top Buyers
| 1 | +$21.4M | |
| 2 | +$9.86M | |
| 3 | +$5.16M | |
| 4 |
BlackRock
New York
|
+$5.11M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$4.7M |
Top Sellers
| 1 | -$8.43M | |
| 2 | -$7.48M | |
| 3 | -$6.01M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.54M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.47M |